INTEGRA LIFESCIENCES HOLDINGS CORP Future Amortization Expense, Remainder of Fiscal Year (Deprecated 2012-01-31)
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) reported Future Amortization Expense, Remainder of Fiscal Year (Deprecated 2012-01-31) of $25.20 million for the 3-month period ending 2012-03-31, per its 10-Q filed 2012-04-26.
Discontinued › Expense Statement › Operating Expenses
us-gaap:FutureAmortizationExpenseRemainderOfFiscalYear · last filed 2012-04-26
- INTEGRA LIFESCIENCES HOLDINGS CORP future amortization expense, remainder of fiscal year (deprecated 2012-01-31) for the quarter ending 2012-03-31 was $25.20M.
| Period end | Future Amortization Expense, Remainder of Fiscal Year (Deprecated 2012-01-31) 3 month |
|---|---|
| 2012-03-31 | $25.20M 10-Q · filed 2012-04-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |